Scholars Central

Research articlePublished 3 May 2021

Evaluation of Serum Prolidase Activity and Oxidantâ??Antioxidant Status in Metabolic Syndrome - A Cross-Sectional Study in VIMSAR, Burla

Authors: Madhusmita Acharya, Sumitra Bhoi, Manoj Kumar Yadav

Journal of Evidence-Based Medicine and Healthcare

Volume 8 · Issue 18 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND Prolidase, a member of the matrix metalloproteinase (MMP) family, is a cytosolic imido dipeptidase, which specifically splits imido dipeptides with C-terminal proline or hydroxyproline. We wanted to compare the serum levels of prolidase enzyme activity & total antioxidant status in patients with metabolic syndrome. Increased prolidase activity and decreased total antioxidant status may indicate critical biological activities relevant to pathological events in metabolic syndrome (MetS), and this activity may be a biological indicator of disease. METHODS This cross-sectional study was conducted in the Department of Biochemistry, Veer Surendra Sai Institute of Medical Sciences and Research, Burla. Out of a total of 135 subjects, 45 had metabolic syndrome, 45 were obese without metabolic syndrome and 45 were non-obese healthy controls. RESULTS In MetS group, prolidase levels were significantly higher when compared to obese and control groups (P < 0.001 and P < 0.05 respectively) and also in obese group against control group (P < 0.05). Tacrolimus (TAC) levels were also lesser in MetS and obese groups when compared to those of control group (P < 0.001 and P < 0.05 respectively). Prolidase was negatively correlated with TAC and high density lipoprotein (HDL-C); r = − 0.33, P < 0.1; r = − 0.35, p < 0.08 and positively correlated with body mass index (BMI), waist circumference, systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides (TG), total cholesterol (TC), low density lipoprotein (LDL-C) & TOS (r = 0.42, P = 0.03; r = 0.39 P = 0.05; r = 0.40 P < 0.04; r = +0.44, P = 0.02; r = 0.39, P = 0.05; r = 0.41, P = 0.04 and r = 0.4, P = 0.04, respectively. CONCLUSIONS Increased prolidase activity is closely associated with the medical phenotype of the metabolic syndrome. Increased prolidase activity and decreased total antioxidant status may indicate critical biological activities relevant to pathological events in Mets, and this activity may be a biological indicator of disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Evidence-Based Medicine and Healthcare.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Madhusmita Acharya”
  • BylineArticles whose byline prints “Sumitra Bhoi”
  • BylineArticles whose byline prints “Manoj Kumar Yadav”